A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer

Imagem de Miniatura
Arquivos
art_BASTOS_A_Set_of_miRNAs_Their_Gene_and_Protein_2016.PDF (3 MB)
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2016
Editora
PUBLIC LIBRARY SCIENCE
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
PEREIRA, C. A. B.
POLPO, A.
LIMA, L.
PUGA, R. D.
OSORIO, C. A. B. T.
ACHATZ, M. I.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PLOS ONE, v.11, n.5, article ID e0154325, 21p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Breast cancer (BC) in young adult patients (YA) has a more aggressive biological behavior and is associated with a worse prognosis than BC arising in middle aged patients (MA). We proposed that differentially expressed miRNAs could regulate genes and proteins underlying aggressive phenotypes of breast tumors in YA patients when compared to those arising in MA patients. Objective: Using integrated expression analyses of miRs, their mRNA and protein targets and stromal gene expression, we aimed to identify differentially expressed profiles between tumors from YA-BC and MA-BC. Methodology and Results: Samples of ER+ invasive ductal breast carcinomas, divided into two groups: YA-BC (35 years or less) or MA-BC (50-65 years) were evaluated. Screening for BRCA1/2 status according to the BOADICEA program indicated low risk of patients being carriers of these mutations. Aggressive characteristics were more evident in YA-BC versus MA-BC. Performing qPCR, we identified eight miRs differentially expressed (miR-9, 18b, 33b, 106a, 106b, 210, 518a-3p and miR-372) between YA-BC and MA-BC tumors with high confidence statement, which were associated with aggressive clinicopathological characteristics. The expression profiles by microarray identified 602 predicted target genes associated to proliferation, cell cycle and development biological functions. Performing RPPA, 24 target proteins differed between both groups and 21 were interconnected within a network protein-protein interactions associated with proliferation, development and metabolism pathways over represented in YA-BC. Combination of eight mRNA targets or the combination of eight target proteins defined indicators able to classify individual samples into YA-BC or MA-BC groups. Fibroblast-enriched stroma expression profile analysis resulted in 308 stromal genes differentially expressed between YA-BC and MA-BC. Conclusion: We defined a set of differentially expressed miRNAs, their mRNAs and protein targets and stromal genes that distinguish early onset from late onset ER positive breast cancers which may be involved with tumor aggressiveness of YA-BC.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/14377
Referências
  1. Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373
  2. Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634
  3. Gonzalez-Angulo AM, 2005, CANCER, V103, P2466, DOI 10.1002/cncr.21070
  4. Tichy JR, 2013, J NATL COMPR CANC NE, V11, P1060
  5. Moura RD, 2015, BREAST, V24, P461, DOI 10.1016/j.breast.2015.04.002
  6. Reipas KM, 2013, ONCOTARGET, V4, P329
  7. Wei W, 2013, GENES IMMUN, V14, P1, DOI 10.1038/gene.2012.54
  8. Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014
  9. Gentilini O, 2010, BREAST, V19, P55, DOI 10.1016/j.breast.2009.11.001
  10. Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575
  11. Trape AP, 2012, CANCER GENOM PROTEOM, V9, P297
  12. Gao J, 2015, PATHOL BIOL, V63, P199, DOI 10.1016/j.patbio.2015.07.001
  13. Wu G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1214-0
  14. Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241
  15. Bozoky B, 2013, INT J CANCER, V133, P286, DOI 10.1002/ijc.28035
  16. Petrelli F, 2015, BREAST CANCER RES TR, V153, P477, DOI 10.1007/s10549-015-3559-0
  17. Zhao XX, 2015, INT J CLIN EXP PATHO, V8, P368
  18. O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484
  19. Cancello G, 2013, BREAST, V22, P1046, DOI 10.1016/j.breast.2013.08.006
  20. Welsby I, 2014, J BIOL CHEM, V289, P26642, DOI 10.1074/jbc.M114.589515
  21. Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
  22. Davies AH, 2011, ONCOTARGET, V2, P401
  23. Verghese ET, 2013, J PATHOL, V231, P388, DOI 10.1002/path.4248
  24. de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
  25. Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244
  26. [Anonymous], 2014, INT J PHOTOENERGY, DOI 10.1155/2014/
  27. Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
  28. Iorio MV, 2011, BREAST, V20, pS63, DOI 10.1016/S0960-9776(11)70297-1
  29. Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777
  30. Zheng RH, 2015, J SURG RES, V195, P158, DOI 10.1016/j.jss.2014.12.035
  31. Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460
  32. Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4
  33. Fonseca-Sanchez MA, 2013, ONCOL REP, V30, P2399, DOI 10.3892/or.2013.2691
  34. de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6
  35. Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599
  36. Mandel K, 2013, STEM CELLS DEV, V22, P3114, DOI 10.1089/scd.2013.0249
  37. Samy N, 2010, CANCER BIOMARK, V6, P63, DOI 10.3233/CBM-2009-0119
  38. Ademuyiwa FO, 2015, CANCER-AM CANCER SOC, V121, P1469, DOI 10.1002/cncr.29178
  39. Brinton LA, 2008, J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344
  40. Yin XD, 2014, J AM COLL SURGEONS, V218, P663, DOI 10.1016/j.jamcollsurg.2013.12.020
  41. Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
  42. Gwak JM, 2014, BREAST CANCER RES TR, V147, P39, DOI 10.1007/s10549-014-3069-5
  43. Bacchi LM, 2010, BREAST, V19, P137, DOI 10.1016/j.breast.2010.01.002
  44. Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009
  45. Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
  46. Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1220/JCO.2004.11.046
  47. Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001
  48. Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1
  49. Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134
  50. Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
  51. Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
  52. Tsai ZY, 2011, KAOHSIUNG J MED SCI, V27, P299, DOI 10.1016/j.kjms.2011.03.010
  53. Yau C, 2011, BREAST CANCER RES TR, V126, P803, DOI 10.1007/s10549-011-1345-1
  54. Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868
  55. Azim HA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0427-5
  56. Bastos EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101656
  57. Ben-Hur V, 2013, CELL REP
  58. Cailleau-Thomas A, 2000, GLYCOBIOLOGY
  59. Carraro DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057581
  60. Chen B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-443
  61. Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204
  62. Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199
  63. Finak G, 2008, NAT MED
  64. Fleming JM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-27
  65. Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647
  66. Glénisson Mathilde, 2012, Genes Cancer, V3, P63, DOI 10.1177/1947601912449832
  67. Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839
  68. Marques PC, 2014, OPEN J GENET, V4, P63
  69. Murakami Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-99
  70. Pena-Chilet M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-529
  71. Peng QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060321
  72. Pereira C. A. D. B., 2014, CONFIDENCE STATEMENT
  73. Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019
  74. Rostoker R, 2015, ENDOCR RELAT CANC
  75. Singer CF, 2008, BREAST CANC RES TREA
  76. Szklarczyk D, 2015, NUCL ACIDS RES
  77. Tomita H, 2016, ONCOTARGET, DOI 10.18632/oncotarget.6920
  78. Uehara T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004921
  79. Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100
  80. Uhrhammer Nancy, 2008, Int J Med Sci, V5, P197
  81. Willems L, 2012, CURR ONCOLREP APR
  82. Yau C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2120
  83. Yau C, 2007, BREAST CANCER RES, V9, P59
  84. Zhou S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-231

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/21
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03